![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SEC SUSPECTS INSIDER TRADING IN GLAXO-CNS DEAL
SEC SUSPECTS INSIDER TRADING IN GLAXO-CNS DEAL
The U.S. Securities and Exchange Commission is hunting for investors suspected of profiting from advanced knowledge of GlaxoSmithKline PLC's takeover bid for CNS Inc.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct